Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
Published Online: 2021-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Aarti Gaba•Amy Ford•Andy Polychronis•Angela Scott•Calley Middleton•Carol MacGregor•Cathy Richards•Charlotte Poile•Christian Ottensmeier•Dean A Fennell•Dionysis Papadatos•Gairin Dancey•Gareth Griffiths•Gary Dougherty•Gerard G Hanna•Gillian Price•Jason F Lester•Jay Naik•Jill Gardiner•Joanne Lord•Judith Cave•Kayleigh Hill•Liz Darlison•Lois Mullholand•Lucy Johnson•Lynn Campbell•Mathilda Cominos•Mavis Nye•Meenali Chitnis•Nicola Steele•Paul Shaw•Peter Szlosarek•Peter Wells-Jordan•Petra Jankowska•Raffaele Califano•Sam Chan•Sarah Danson•Sean Ewings•Tom Geldhart
